Dossier Evaluation status

Dossier Evaluation status

Data platform availability banner - dossier evaluation status

The new ECHA CHEM database has been released by ECHA. See for more information on the transition to ECHA CHEM.  More

Please be aware that REACH registration data on the current Dissemination Platform (accessible through the magnifying glass icon in the table) is no longer maintained; it remains frozen as of 19th May 2023. As shown in the support page we hope to move the dossier evaluation information to ECHA CHEM by the end of 2024. Until then, while the assessment status will be updated here, the corresponding registration dossiers will be available only on ECHA CHEM.

We appreciate your understanding during this transition period.


 

Dossier Evaluation status

ECHA’s dossier evaluation process covers compliance checks and the examination of testing proposals. By consulting the table below, you can find out whether ECHA has started to evaluate dossiers for a particular substance and follow the progress through the evaluation process.

The table below displays the type, scope and status of the assessment undertaken for a given dossier. The decision date and the non-confidential version of the decision are published shortly after the decision has been adopted.

Before publishing the non-confidential version of an adopted decision on its website, ECHA consults the addressees of the decision on this version. ECHA systematically removes any personal data from the non-confidential version of a decision. Some sections may also be redacted based on justified claims by registrants, regarding information confidential or deemed to harm their commercial interest if disclosed.

Check the expandable boxes below for more details.

 

Content of the table

Identifiers of the substance: Name (as on the Dissemination website); EC/List number (European Community number / List number assigned by ECHA); CAS number (also called the Chemical Abstract Service Registry Number or CAS RN).

Decision type can be ‘CCH’ for Compliance Check Evaluation and ‘TPE’ for Testing Proposal Evaluation.

Scope refers to the scope of the evaluation and can be:

  • Targeted: The compliance check focuses only on some endpoints.
  • Comprehensive: The compliance check focuses on all relevant endpoints under ECHA’s strategy.
  • Testing proposal: The assessment focuses on the testing proposals submitted by the registrants.

Status reports the current position of the dossier in the dossier evaluation process and can be:

  • Under assessment: The evaluation of the dossier has formally started.
  • Ongoing: The registrants have received the draft decision - The dossier retains this status until the decision is adopted or the evaluation is otherwise concluded.
  • Information requested: The registrants have received the adopted decision with the deadline for providing the requested information.
  • Follow-up: The deadline set in the adopted decision has passed, and ECHA is assessing whether the information requested in the decision has been provided in the dossier update - This follow-up may also involve the national enforcement authorities.
  • Concluded: The evaluation is closed.
    In most cases, this means that the registrant has responded to the adopted decision with compliant information. However, as in some cases an evaluation is concluded at an earlier stage, an adopted decision is not always available for every evaluation marked as concluded.

Decision date reports the date on which the adopted decision was sent to the registrants.

Decision displays a non-confidential version of the adopted decision once available.

Latest update indicates the date of the latest automatic update carried out by ECHA’s information systems.

Unless confidentiality is claimed on the substance identifiers, you can access the disseminated registration dossiers for the substance in ECHA CHEM. From the table below, click on the substance name link to access the Substance Infocard. From there you will find a link to direct you to the ECHA CHEM substance Dashboard and the REACH registration dossier(s). You can also go directly to ECHA CHEM and search with substance identifiers. 

The magnifying glass icon leads to information on the current dissemination platform that has not been updated since May 2023. We apologise for the inconvenience and appreciate your understanding during the transition period. 

You can access additional information in ‘Details’ view, by clicking on the eye icon:

  • Substance identifiers
  • Decision type (CCH or TPE), scope and status of the evaluation, as in the main table
  • Decision’s deadline(s): The deadline(s) for requested information contained in the decision, should the decision contain more than one deadline
  • Appeal information: If the registrants have appealed against the adopted decision, a link to the Board of Appeal’s announcement document is provided.

 

How to read the table

ECHA’s information systems automatically update the status of dossier evaluations during the process. For transparency reasons, all dossier evaluation decisions will remain published. This also applies if the registrants have appealed or have updated the registration dossier as requested in the decision.

It is for the reader to verify the status of an evaluation: check the deadline of the decision, the indicated status of the evaluation, and the content of the registration dossier. The most recent registration data on a substance is available in the ECHA CHEM database; check also whether the Board of Appeal has taken a decision regarding any appeal.

 

Important notes:

  • The dossier evaluation decisions may not apply to all registrants that are part of a joint registration.
  • There may be a delay between the decision date and the actual publication of the adopted decision, which corresponds to the consultation on its non-confidential version and addressing any comments from the registrants.
Last updated 24 April 2024. Database contains 4165 unique substances/entries.
Filter the list
Decision's deadline:
Decision date:

The List does not contain any Substances.
Decision    
435-860-1
214417-91-1
TPE
Testing Proposal
Concluded
20-Jan-2021
17-Apr-2024
View
Details
435-790-1
297730-93-9
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
435-740-7
94317-64-3
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
435-740-7
94317-64-3
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
434-880-6
-
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
434-850-2
1680-31-5
CCH
Comprehensive
Concluded
03-Nov-2011
26-Nov-2022
View
Details
434-850-2
1680-31-5
CCH
Comprehensive
Ongoing
09-Nov-2023
View
Details
434-800-1
-
CCH
Comprehensive
Concluded
25-Apr-2018
26-Nov-2022
View
Details
434-440-3
-
CCH
Comprehensive
Ongoing
11-Dec-2023
View
Details
434-430-9
-
TPE
Testing Proposal
Concluded
05-Dec-2017
26-Nov-2022
View
Details
434-430-9
-
TPE
Testing Proposal
Concluded
27-Jul-2015
10-Aug-2023
View
Details
434-430-9
-
TPE
Testing Proposal
Follow-up
23-Feb-2021
09-Feb-2023
View
Details
434-430-9
-
CCH
Comprehensive
Concluded
10-Aug-2023
View
Details
434-430-9
-
CCH
Comprehensive
Information requested
13-Feb-2024
11-Apr-2024
View
Details
434-280-4
-
CCH
Comprehensive
Information requested
19-Jan-2024
18-Mar-2024
View
Details
434-070-2
-
TPE
Testing Proposal
Concluded
03-Feb-2012
26-Nov-2022
View
Details
434-070-2
-
TPE
Testing Proposal
Concluded
28-Nov-2013
26-Nov-2022
View
Details
433-480-9
623-53-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
433-480-9
623-53-0
TPE
Testing Proposal
Follow-up
13-Dec-2018
26-Nov-2022
View
Details
433-260-2
-
TPE
Testing Proposal
Concluded
12-Jul-2011
26-Nov-2022
View
Details
433-060-5
290822-07-0
CCH
Comprehensive
Concluded
10-Mar-2020
26-Nov-2022
View
Details
432-840-2
220926-97-6
CCH
Targeted
Concluded
16-Jun-2011
26-Nov-2022
View
Details
432-840-2
220926-97-6
TPE
Testing Proposal
Concluded
16-Jun-2011
26-Nov-2022
View
Details
432-770-2
139189-30-3
CCH
Comprehensive
Information requested
17-Oct-2022
09-Feb-2023
View
Details
432-550-6
243858-01-7
TPE
Testing Proposal
Ongoing
19-Dec-2023
View
Details
432-520-2
232938-43-1
CCH
Comprehensive
Concluded
17-Sep-2019
26-Nov-2022
View
Details
432-400-1
10102-09-7
TPE
Testing Proposal
Concluded
23-Jun-2022
26-Nov-2022
View
Details
432-240-0
12056-51-8
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
432-240-0
12056-51-8
CCH
Comprehensive
Concluded
05-Sep-2016
26-Nov-2022
View
Details
432-240-0
12056-51-8
TPE
Testing Proposal
Concluded
09-Apr-2018
26-Nov-2022
View
Details
432-240-0
12056-51-8
CCH
Targeted
Concluded
26-Nov-2022
View
Details
432-240-0
12056-51-8
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
432-240-0
12056-51-8
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
432-240-0
12056-51-8
CCH
Targeted
Under assessment
23-Nov-2023
View
Details
432-240-0
12056-51-8
CCH
Comprehensive
Under assessment
09-Nov-2023
View
Details
432-240-0
12056-51-8
CCH
Comprehensive
Under assessment
09-Nov-2023
View
Details
432-240-0
12056-51-8
CCH
Comprehensive
Under assessment
09-Nov-2023
View
Details
432-240-0
12056-51-8
CCH
Comprehensive
Under assessment
09-Nov-2023
View
Details
432-130-2
119345-01-6
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
432-130-2
119345-01-6
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
432-130-2
119345-01-6
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
432-080-1
-
CCH
Comprehensive
Follow-up
25-Apr-2022
18-May-2023
View
Details
432-070-7
-
TPE
Testing Proposal
Concluded
24-Oct-2011
26-Nov-2022
View
Details
431-890-2
166412-78-8
CCH
Comprehensive
Information requested
30-Aug-2022
09-Feb-2023
View
Details
431-830-5
-
CCH
Comprehensive
Ongoing
13-Jan-2023
View
Details
431-700-8
259823-90-0
CCH
Comprehensive
Concluded
26-Apr-2017
26-Nov-2022
View
Details
431-700-8
259823-90-0
CCH
Targeted
Follow-up
14-Mar-2022
26-Nov-2022
View
Details
431-090-3
190085-41-7
CCH
Comprehensive
Information requested
18-Apr-2023
14-Jun-2023
View
Details
430-960-1
-
CCH
Targeted
Concluded
26-Nov-2022
View
Details
430-550-0
1671-49-4
TPE
Testing Proposal
Concluded
29-Mar-2012
26-Nov-2022
View
Details
429-900-5
82356-51-2
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
429-750-0
180898-37-7
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
429-600-4
1026988-42-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
429-320-2
24748-23-0
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
429-320-2
24748-23-0
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
429-320-2
24748-23-0
TPE
Testing Proposal
Under assessment
25-Jul-2023
View
Details
PYRAZOL P5; PYRAZOLE DHE
429-300-3
155601-30-2
CCH
Targeted
Concluded
17-Dec-2010
26-Nov-2022
View
Details
429-280-6
151900-44-6
TPE
Testing Proposal
Concluded
01-Jul-2011
26-Nov-2022
View
Details
429-280-6
151900-44-6
CCH
Comprehensive
Concluded
29-Nov-2022
View
Details
429-280-6
151900-44-6
CCH
Comprehensive
Information requested
20-Feb-2024
19-Apr-2024
View
Details
429-270-1
136210-30-5
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
429-200-1
-
CCH
Targeted
Under assessment
23-Nov-2023
View
Details
429-200-1
-
CCH
Comprehensive
Ongoing
18-Apr-2024
View
Details
SCARLET DER 8107
429-070-4
214362-06-8
TPE
Testing Proposal
Information requested
25-Apr-2022
09-Feb-2023
View
Details
SCARLET DER 8107
429-070-4
214362-06-8
CCH
Comprehensive
Information requested
25-Apr-2022
09-Feb-2023
View
Details
429-040-0
272460-97-6
CCH
Comprehensive
Ongoing
04-Apr-2024
View
Details
428-710-1
207574-76-3
CCH
Comprehensive
Concluded
10-Feb-2012
26-Nov-2022
View
Details
428-310-5
225789-38-8
TPE
Testing Proposal
Concluded
06-Jun-2012
26-Nov-2022
View
Details
428-310-5
225789-38-8
TPE
Testing Proposal
Concluded
11-Jan-2022
05-Oct-2023
View
Details
428-310-5
225789-38-8
TPE
Testing Proposal
Concluded
30-Nov-2018
26-Nov-2022
View
Details
428-310-5
225789-38-8
CCH
Comprehensive
Ongoing
07-Mar-2024
View
Details
427-370-1
164288-56-6
TPE
Testing Proposal
Concluded
19-Apr-2024
View
Details
426-730-3
123439-82-7
TPE
Testing Proposal
Concluded
08-Jul-2019
26-Nov-2022
View
Details
426-650-9
191743-75-6
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
SR-245
426-040-2
25713-60-4
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
SR-245
426-040-2
25713-60-4
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
SR-245
426-040-2
25713-60-4
TPE
Testing Proposal
Concluded
17-Jul-2012
26-Nov-2022
View
Details
SR-245
426-040-2
25713-60-4
CCH
Targeted
Concluded
26-Nov-2022
View
Details
SR-245
426-040-2
25713-60-4
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
SR-245
426-040-2
25713-60-4
CCH
Comprehensive
Information requested
14-Feb-2024
15-Apr-2024
View
Details
425-950-7
187393-00-6
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
425-950-7
187393-00-6
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
425-220-8
5945-33-5
TPE
Testing Proposal
Concluded
28-Feb-2012
26-Nov-2022
View
Details
425-220-8
5945-33-5
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
425-220-8
5945-33-5
TPE
Testing Proposal
Concluded
25-Jul-2011
26-Nov-2022
View
Details
425-220-8
5945-33-5
TPE
Testing Proposal
Concluded
04-Jul-2012
26-Nov-2022
View
Details
425-220-8
5945-33-5
TPE
Testing Proposal
Concluded
04-Jul-2012
26-Nov-2022
View
Details
425-220-8
5945-33-5
CCH
Comprehensive
Information requested
22-Sep-2021
09-Feb-2023
View
Details
425-220-8
5945-33-5
CCH
Comprehensive
Concluded
09-Jun-2022
View
Details
425-220-8
5945-33-5
CCH
Comprehensive
Information requested
22-Sep-2021
09-Feb-2023
View
Details
425-220-8
5945-33-5
TPE
Testing Proposal
Information requested
08-Nov-2022
14-Feb-2023
View
Details
425-220-8
5945-33-5
CCH
Comprehensive
Information requested
22-Sep-2021
09-Feb-2023
View
Details
425-220-8
5945-33-5
TPE
Testing Proposal
Information requested
08-Nov-2022
14-Feb-2023
View
Details
425-050-4
10217-34-2
CCH
Comprehensive
Ongoing
04-Dec-2023
View
Details
CGL 116
425-020-0
191680-81-6
CCH
Comprehensive
Follow-up
21-Feb-2020
26-Nov-2022
View
Details
CGL 116
425-020-0
191680-81-6
TPE
Testing Proposal
Concluded
17-Jun-2013
26-Nov-2022
View
Details
424-640-9
202842-98-6
CCH
Targeted
Concluded
26-Nov-2022
View
Details
424-210-0
23911-85-5
CCH
Comprehensive
Follow-up
04-May-2022
22-May-2023
View
Details
MIGLYOL 8810
424-180-9
-
CCH
Comprehensive
Follow-up
05-May-2021
26-Nov-2022
View
Details
423-900-9
10009-20-8
CCH
Comprehensive
Concluded
26-Nov-2022
Details
423-740-1
10461-98-0
CCH
Comprehensive
Concluded
31-Jul-2023
View
Details
423-740-1
10461-98-0
CCH
Comprehensive
Concluded
01-Mar-2024
View
Details
423-740-1
10461-98-0
CCH
Comprehensive
Ongoing
24-Aug-2023
View
Details
423-630-1
-
CCH
Comprehensive
Concluded
11-Oct-2023
View
Details
CGI 819
423-340-5
162881-26-7
CCH
Targeted
Concluded
27-Mar-2012
26-Nov-2022
View
Details
CGI 819
423-340-5
162881-26-7
TPE
Testing Proposal
Concluded
27-Mar-2012
26-Nov-2022
View
Details
CGI 819
423-340-5
162881-26-7
CCH
Comprehensive
Ongoing
19-Apr-2024
View
Details
CGI 819
423-340-5
162881-26-7
CCH
Comprehensive
Ongoing
19-Apr-2024
View
Details
CGI 819
423-340-5
162881-26-7
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
CGI 819
423-340-5
162881-26-7
CCH
Comprehensive
Ongoing
19-Apr-2024
View
Details
423-300-7
911674-82-3
CCH
Comprehensive
Concluded
05-Oct-2023
View
Details
423-300-7
911674-82-3
CCH
Targeted
Concluded
18-Dec-2023
View
Details
423-300-7
911674-82-3
CCH
Comprehensive
Information requested
13-Feb-2024
11-Apr-2024
View
Details
423-270-5
164462-16-2
CCH
Targeted
Concluded
12-Oct-2010
26-Nov-2022
View
Details
423-270-5
164462-16-2
CCH
Comprehensive
Ongoing
24-Apr-2024
Details
422-600-5
73936-91-1
TPE
Testing Proposal
Under assessment
09-Jun-2022
View
Details
KHUSINIL
422-580-8
75490-39-0
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
CASSIFFIX
422-040-1
426218-78-2
CCH
Comprehensive
Concluded
20-Apr-2016
26-Nov-2022
View
Details
421-920-2
154862-43-8
CCH
Comprehensive
Ongoing
05-Dec-2023
View
Details
421-920-2
154862-43-8
CCH
Comprehensive
Ongoing
05-Dec-2023
View
Details
421-920-2
154862-43-8
CCH
Comprehensive
Ongoing
05-Dec-2023
View
Details
421-880-6
201792-73-6
CCH
Comprehensive
Information requested
17-Nov-2022
20-Feb-2023
View
Details
CD 28-0132; IRGALUBE 232
421-820-9
192268-65-8
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
CD 28-0132; IRGALUBE 232
421-820-9
192268-65-8
CCH
Comprehensive
Concluded
03-May-2016
26-Nov-2022
View
Details
CD 28-0132; IRGALUBE 232
421-820-9
192268-65-8
TPE
Testing Proposal
Under assessment
09-Nov-2023
View
Details
CD 28-0132; IRGALUBE 232
421-820-9
192268-65-8
TPE
Testing Proposal
Concluded
30-Jul-2015
26-Nov-2022
View
Details
3,4-DIACETOXY-1-BUTENE
421-720-5
18085-02-4
TPE
Testing Proposal
Information requested
16-Jun-2022
09-Feb-2023
View
Details
421-450-8
154702-15-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
421-450-8
154702-15-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
421-140-2
-
CCH
Comprehensive
Concluded
05-Apr-2024
View
Details
421-090-1
131298-44-7
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
421-090-1
131298-44-7
CCH
Comprehensive
Follow-up
21-Jan-2021
26-Nov-2022
View
Details
420-640-8
-
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
EXPERIMENTAL CROSSLINKER S17762-80(S); MELAMINE BASED CROSSLINKER (MBC); TACT
420-390-1
187547-46-2
CCH
Targeted
Concluded
31-May-2011
26-Nov-2022
View
Details
NYLOSTAB S-EED; NYSEED
419-710-0
42774-15-2
TPE
Testing Proposal
Concluded
14-Sep-2016
26-Nov-2022
View
Details
AUFHELLER 2001; ELV 1094
419-060-8
79026-02-1
CCH
Comprehensive
Information requested
08-Nov-2023
05-Mar-2024
View
Details
ADK STAB HP-10
418-310-3
126050-54-2
CCH
Comprehensive
Ongoing
06-Mar-2024
View
Details
ACRYLOYLMORPHOLIN
418-140-1
5117-12-4
TPE
Testing Proposal
Follow-up
02-Jun-2021
14-Mar-2023
View
Details
ACRYLOYLMORPHOLIN
418-140-1
5117-12-4
CCH
Comprehensive
Follow-up
02-Jun-2021
06-Apr-2023
View
Details
PDN 2287
417-450-2
-
TPE
Testing Proposal
Information requested
14-Feb-2024
15-Apr-2024
View
Details
417-310-0
72903-27-6
TPE
Testing Proposal
Concluded
23-Aug-2017
26-Nov-2022
View
Details
417-310-0
72903-27-6
CCH
Comprehensive
Information requested
12-Jun-2023
13-Jul-2023
View
Details
1-DODECENE TRIMER, HYDROGENATED; ALKANE 4
417-070-7
151006-62-1
TPE
Testing Proposal
Under assessment
09-Jun-2022
View
Details
1-DODECENE DIMER, HYDROGENATED; ALKANE 2
417-060-2
151006-61-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
1-DODECENE DIMER, HYDROGENATED; ALKANE 2
417-060-2
151006-61-0
TPE
Testing Proposal
Under assessment
09-Jun-2022
View
Details
TMAP
416-900-5
79723-02-7
CCH
Comprehensive
Information requested
20-Jun-2023
18-Jul-2023
View
Details
416-600-4
-
TPE
Testing Proposal
Concluded
23-Mar-2017
26-Nov-2022
View
Details
416-600-4
-
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
416-530-4
178949-82-1
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
416-510-5
-
TPE
Testing Proposal
Concluded
05-Oct-2010
26-Nov-2022
View
Details
416-510-5
-
CCH
Comprehensive
Ongoing
08-Aug-2023
View
Details
416-250-2
84632-59-7
TPE
Testing Proposal
Concluded
15-Oct-2013
26-Nov-2022
View
Details
IRGAFOS 38
416-140-4
145650-60-8
CCH
Comprehensive
Ongoing
21-Nov-2023
View
Details
IRGAFOS 38
416-140-4
145650-60-8
CCH
Comprehensive
Concluded
15-Jan-2024
View
Details
IRGAFOS 38
416-140-4
145650-60-8
CCH
Comprehensive
Concluded
04-Mar-2024
View
Details
HELVETOLIDE
415-490-5
141773-73-1
CCH
Comprehensive
Concluded
19-May-2017
26-Nov-2022
View
Details
HELVETOLIDE
415-490-5
141773-73-1
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
SPE 93279
414-420-0
-
TPE
Testing Proposal
Concluded
23-Mar-2015
26-Nov-2022
View
Details
413-920-6
88949-33-1
TPE
Testing Proposal
Concluded
11-Oct-2013
26-Nov-2022
View
Details
LUPEROX 610-E-35; LUPEROX 610-E-50; LUPEROX 610-EN-50; LUPEROX 610-M-50; LUPERSOL 610; LUPERSOL 610-M-50
413-910-1
1467668-33-2
TPE
Testing Proposal
Concluded
17-Jun-2013
26-Nov-2022
View
Details
413-890-4
-
CCH
Comprehensive
Follow-up
18-May-2021
26-Nov-2022
View
Details
ANOX 1315; ANOX BF; DURAD AX 38
413-750-2
171090-93-0
TPE
Testing Proposal
Information requested
02-May-2022
09-Feb-2023
View
Details
RAPICURE CHVE
413-370-7
17351-75-6
CCH
Targeted
Concluded
03-May-2010
26-Nov-2022
View
Details
413-090-5
-
CCH
Comprehensive
Information requested
13-Oct-2023
09-Feb-2024
View
Details
413-060-1
134376-16-2
CCH
Comprehensive
Information requested
18-Jan-2024
18-Mar-2024
View
Details
ADDITIV 104
412-780-3
1380226-46-9
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
ADDITIV 104
412-780-3
1380226-46-9
TPE
Testing Proposal
Concluded
28-Sep-2011
26-Nov-2022
View
Details
PERKALINK 900
412-570-1
119462-56-5
TPE
Testing Proposal
Concluded
05-Dec-2017
26-Nov-2022
View
Details
PERKALINK 900
412-570-1
119462-56-5
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
412-440-4
2725-22-6
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
MP DIOL(R) GLYCOL
412-350-5
2163-42-0
TPE
Testing Proposal
Under assessment
30-Nov-2023
View
Details
AMBER CORE
412-300-2
139504-68-0
TPE
Testing Proposal
Follow-up
24-Jan-2022
02-Aug-2023
View
Details
AMBER CORE
412-300-2
139504-68-0
TPE
Testing Proposal
Concluded
10-Sep-2012
26-Nov-2022
View
Details
FLORHYDRAL
412-050-4
125109-85-5
CCH
Comprehensive
Ongoing
06-Apr-2023
View
Details
FLORHYDRAL
412-050-4
125109-85-5
CCH
Comprehensive
Concluded
27-Sep-2023
View
Details
SANDUVOR 3058; SANDUVOR 3058 LIQ.
411-930-5
106917-31-1
TPE
Testing Proposal
Information requested
12-Sep-2023
08-Nov-2023
View
Details
KY-MA
411-790-5
54390-87-3
CCH
Targeted
Concluded
26-Nov-2022
View
Details
KY-MA
411-790-5
54390-87-3
CCH
Comprehensive
Follow-up
02-Nov-2021
26-Nov-2022
View
Details
HÄRTER VERSUCHSPRODUKT LS 2959E; HÄRTER VP LS 2959E
411-700-4
140921-24-0
TPE
Testing Proposal
Information requested
11-Jan-2023
24-Feb-2023
View
Details
HÄRTER VERSUCHSPRODUKT LS 2959E; HÄRTER VP LS 2959E
411-700-4
140921-24-0
TPE
Testing Proposal
Concluded
27-Jul-2015
26-Nov-2022
View
Details
HÄRTER VERSUCHSPRODUKT LS 2959E; HÄRTER VP LS 2959E
411-700-4
140921-24-0
CCH
Targeted
Concluded
18-May-2023
View
Details
POLYSANTOL
411-580-3
107898-54-4
CCH
Targeted
Concluded
27-Jul-2011
26-Nov-2022
View
Details
TG-SA
411-570-9
41481-66-7
CCH
Targeted
Concluded
26-Nov-2022
View
Details
CG 30-1577
411-380-6
147315-50-2
TPE
Testing Proposal
Concluded
07-Jun-2013
26-Nov-2022
View
Details
MR-8A; MR-N2; NBDI
411-280-2
74091-64-8
TPE
Testing Proposal
Concluded
30-Mar-2014
26-Nov-2022
View
Details
MR-8A; MR-N2; NBDI
411-280-2
74091-64-8
TPE
Testing Proposal
Concluded
17-Nov-2017
26-Nov-2022
View
Details
MR-8A; MR-N2; NBDI
411-280-2
74091-64-8
CCH
Comprehensive
Follow-up
13-Nov-2019
26-Nov-2022
View
Details
CG 27-145
411-220-5
134701-20-5
TPE
Testing Proposal
Concluded
03-Jun-2013
26-Nov-2022
View
Details
KY-ET
411-070-0
-
CCH
Comprehensive
Follow-up
02-Nov-2021
26-Nov-2022
View
Details
MEXORYL SX; SX 32
410-960-6
92761-26-7
CCH
Targeted
Concluded
26-Nov-2022
View
Details
ITC 288/S
410-800-5
-
TPE
Testing Proposal
Concluded
20-Dec-2012
26-Nov-2022
View
Details
CGL 400
410-560-1
-
TPE
Testing Proposal
Concluded
15-May-2013
26-Nov-2022
View
Details
ADK STAB PEP-36
410-290-4
80693-00-1
CCH
Comprehensive
Ongoing
09-Jan-2024
View
Details
ADK STAB PEP-36
410-290-4
80693-00-1
CCH
Comprehensive
Ongoing
09-Jan-2024
View
Details
2-BUTYL-4-CHLORO-5-FORMYLIMIDAZOLE; BCFI
410-260-0
83857-96-9
CCH
Targeted
Concluded
26-Nov-2022
View
Details
MCP 968
410-190-0
132983-41-6
CCH
Targeted
Concluded
26-Nov-2022
View
Details
MCP 968
410-190-0
132983-41-6
CCH
Comprehensive
Follow-up
14-May-2020
28-Nov-2022
View
Details
INTEROX-PMBP-70W; INTEROX-PMPB-70W
407-950-9
895-85-2
TPE
Testing Proposal
Under assessment
19-Feb-2024
View
Details
INTEROX-PMBP-70W; INTEROX-PMPB-70W
407-950-9
895-85-2
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
D(+)-LACTATE D'ISOBUTYLE
407-770-0
61597-96-4
CCH
Comprehensive
Concluded
14-Aug-2023
View
Details

Export search results to: